Ann: Imugene and RenovoRx CF33 Virotherapy Delivery Collaboration, page-42

perfectly legitimate question, and no doubt was on a few posters minds. My take FWIW is that indeed it still does seek and destroy on its own via IV, but using this tech may make it even that more effective, and therefore even more targeted to help those that have very advanced, late stage diagnosis, and they need a supercharged approach rather than waiting for the immune system which what would inevitably take longer naturally.
Any tech that can speed up a process is worth looking at. I think the 4mo th collaboration is a great indicator as to whether this can work faster than the human body’s natural system. It is a race against growing cancer cells, the quicker the better!